What is the market doing?
What the tape says about AMRX
Amneal Pharmaceuticals, Inc. is +84% over the past year while the S&P 500 is +20%: 64 points ahead of the market.
+84%
1-year return · S&P 500 +20%
- vs 200-day average
- +22%
vs 200-day average · a clear uptrend
- RSI (14)
- 27
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 9.5%
Below its 52-week high
Details›
- Last close2026-09-08
- $17.06
- 1 monthS&P 500 −0.30%
- −5.6%
- 1 yearS&P 500 +20%
- +84%
- 5 yearsS&P 500 +85%
- +238%
- vs 50-day average$17.45
- −2.2%
- 52-week high
- $18.86
- 52-week low
- $9.28
- Annualised volatility
- 33%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$451K
| Year | Return |
|---|---|
| 2026 (year to date) | +35% |
| 2025 | +59% |
| 2024 | +30% |
| 2023 | +205% |
| 2022 | −58% |
| 2021 | +4.8% |
| 2020 | −5.2% |
| 2019 | −64% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 4 of 8 | −0.85% |
| Feb | 8 | 6 of 8 | +1.6% |
| Mar | 8 | 3 of 8 | −3.0% |
| Apr | 8 | 3 of 8 | +0.40% |
| May | 8 | 5 of 8 | +2.4% |
| Jun | 9 | 3 of 9 | +2.6% |
| Jul | 9 | 5 of 9 | −1.1% |
| Aug | 9 | 5 of 9 | +2.5% |
| Sep | 9 | 3 of 9 | −0.71% |
| Oct | 8 | 6 of 8 | +1.2% |
| Nov | 8 | 4 of 8 | +3.8% |
| Dec | 8 | 5 of 8 | +6.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #22 of 29 by Smart Score